Eastern Bank’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$154K Buy
430
+157
+58% +$48K ﹤0.01% 428
2026
Q1
$68.4K Hold
273
﹤0.01% 522
2025
Q4
$75.1K Hold
273
﹤0.01% 507
2025
Q3
$71.6K Hold
273
﹤0.01% 503
2025
Q2
$59.7K Hold
273
﹤0.01% 523
2025
Q1
$61.1K Hold
273
﹤0.01% 524
2024
Q4
$89.4K Hold
273
﹤0.01% 486
2024
Q3
$81.9K Buy
+273
New +$83.6K ﹤0.01% 492

Other funds holding WST

Eastern Bank's WST Position: Q2 2026 in Review

Eastern Bank increased its West Pharmaceutical (WST) stake by 58% in Q2 2026, buying an estimated $48K and bringing the position to 430 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Eastern Bank first reported a position in WST in Q3 2024 and has held it in 8 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Eastern Bank held 430 shares of West Pharmaceutical worth $154K as of Q2 2026.
  • Eastern Bank bought 157 West Pharmaceutical shares in Q2 2026, an estimated $48K.
  • West Pharmaceutical made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #428 holding.
  • Eastern Bank first reported a position in West Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.